Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Antidepressants.
- Who it may be relevant to
- Registry conditions: Chronic Kidney Disease(CKD), Depression. Basic parameters: 18 years — 90 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Cohort Study on the Psychiatric Outcomes and Genetic Associations in Patients With Chronic Kidney Disease
Overview
By using genetic information we could predict the prevalence of mood disorder and response to treatment.
Detailed description
This prospective cohort study enrols patients with chronic kidney disease and gathers genetic information. By the patient's biochemical information, including genetic information, we could predict the prevalence of mood disorder and response to the antipsychotherapy.
Interventions
- Other Antidepressants
control
Primary outcome measures
- Prevalence of depression [Time frame: 10 years]
Eligibility criteria
Inclusion criteria
- CKD patients aged 18 to 90 years
Exclusion criteria
- no CKD patients, aged below 18 or above 90 years
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06675396 · CKD gene · CKD Research Institute